Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.93M Buy
48,496
+6,269
+15% +$964K 0.13% 105
2025
Q4
$7.35M Buy
42,227
+37,679
+828% +$6.88M 0.13% 123
2025
Q3
$655K Sell
4,548
-33
-0.7% -$4.04K 0.01% 214
2025
Q2
$461K Hold
4,581
0.01% 262
2025
Q1
$349K Buy
4,581
+825
+22% +$63.1K 0.01% 284
2024
Q4
$259K Buy
+3,756
New +$271K 0.01% 266

Other funds holding INSM

GF Fund Management's INSM Position: Q1 2026 in Review

GF Fund Management increased its Insmed (INSM) stake by 15% in Q1 2026, buying an estimated $964K and bringing the position to 48,496 shares worth $7.93M. The position accounts for 0.13% of the portfolio, ranked #105.

GF Fund Management first reported a position in INSM in Q4 2024 and has held it in 6 quarters since. 669 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

  • GF Fund Management held 48,496 shares of Insmed worth $7.93M as of Q1 2026.
  • GF Fund Management bought 6,269 Insmed shares in Q1 2026, an estimated $964K.
  • Insmed made up 0.13% of GF Fund Management's portfolio in Q1 2026, its #105 holding.
  • GF Fund Management first reported a position in Insmed in Q4 2024 and has held it in 6 quarters since.
  • 669 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on GF Fund Management's 13F filing for Q1 2026, filed 15 Apr 2026.